Latest News and Press Releases
Want to stay updated on the latest news?
-
New York, NY, June 22, 2026 (GLOBE NEWSWIRE) -- Matrix Applications, a leading provider of financial technology and operational solutions in the capital markets, marks its fourth year earning...
-
Delray Beach, FL , June 22, 2026 (GLOBE NEWSWIRE) -- The report "Handheld Thermal Camera Market by Profession Type (Electricians, HVAC, Building Inspectors), Distribution Channel (Manufacturer...
-
TEL AVIV, Israel, June 22, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative...
-
PHILADELPHIA, June 22, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development...
-
Boehringer Ingelheim is committed to improving outcomes for people facing aggressive cancers where there are currently few treatment optionsDAREON®-Lung-1 and DAREON®-NEC-1 will evaluate obrixtamig as...
-
Investors who lost money in EMBC after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
New class action for Embecta (EMBC) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 8/17/2026
-
EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with the Schall Law Firm
-
NEW YORK, June 19, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Embecta Corp. (NASDAQ: EMBC). Shareholders who purchased shares of EMBC during the...
-
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Embecta (EMBC) To Contact Him Directly To Discuss Their Options If you purchased or...